The Private Equity and Healthcare teams advised Elligo Health Research® in its acquisition of ClinEdge, a research practice management and clinical services organization for clinical research sites, pharma companies, and clinical research organizations. The transaction includes GuideStar Research and BTC of New Bedford.
The transaction of $135 million was funded through new co-lead investors Morgan Stanley Expansion Capital and Ally Bridge, along with participation from Norwest Venture Partners and all major existing investors, including Cerner, Hatteras Venture Partners, Noro-Moseley Partners, Piper Sandler Merchant Banking, Shumway Capital, and Syneos Health. Goodwin also represented Elligo in the $135 million Series E financing round.
Elligo Health Research, a healthcare-enabling research organization powered by its novel IntElligo Research Stack technology, uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option.
The Goodwin team was led by John LeClaire, Roger Cohen, Beth Withers, Janet Andolina, Jake Osborn, Ai Tajima, Jeffrey Koh, Caddy Yates, Paul Thompson and Federica De Santis.
For additional details on the acquisition, please read the press release.